News | March 09, 2010

Thallium Imaging Offers Alternative During Isotope Shortage

Dual-isotope imaging: reduced-dose, shorter-scan-time stress images acquired with 20 mCi Tc-99m at 10 sec/frame. Photo courtesy of Mayo Clinic.

Dual-isotope imaging: reduced-dose, shorter-scan-time stress images acquired with 20 mCi Tc-99m at 10 sec/frame. Photo courtesy of Mayo Clinic.

Dual-isotope imaging: reduced-dose, shorter-scan-time rest images acquired with 2mCi Tl-201 at 20 sec/frame. Photo courtesy of Mayo Clinic.

Dual-isotope imaging: reduced-dose, shorter-scan-time rest images acquired with 2mCi Tl-201 at 20 sec/frame. Photo courtesy of Mayo Clinic.

March 9, 2010 – As an alternative to the technetium (Tc-99M) isotope used in many nuclear imaging studies, UltraSPECT is advocating the use of thallium isotope (TI-201) imaging as an alternative. Due to the impact of the Canadian reactor shutdown combined with the recently announced six-month repair plan of the Dutch reactor, the global shortage of Tc-99m is expected to remain grave in the next few months, leaving nuclear medicine in a precarious position. The shortage means there is an inability to provide patients with needed tests, longer delays in exam scheduling, use of reduced-dose imaging protocols, and loss of business to other imaging modalities such as CTA, echo and cardiac PET. The company offers two cardiac products, Xpress.Cardiac and Xpert3.Cardiac, which support Tl-201 imaging. These products utilize UltraSPECT's proprietary WBR image reconstruction capabilities to enable reduced-dose and enhanced-resolution thallium imaging. The products allow the utilization of lower dose imaging protocols using Tc-99m with no compromise in terms of imaging acquisition times and diagnostic value. They also support reduced-dose and enhanced-resolution Tl-201 imaging, helping alleviating the impact of the technetium shortage while reducing patient radiation exposure. UltraSPECT products feature connectivity to the imaging systems of all three major nuclear medicine camera manufacturers. “UltraSPECT has allowed us to acquire high-quality gated SPECT images with Tl-201, without increasing scan times,” said John Zeitz, M.D., chief of nuclear medicine at Beaumont Hospital in Troy, Mich. “Previously, we would have to increase our imaging time by 50 percent in order to achieve decent image quality for the gated cine reconstruction." The one-day dual-isotope (Tl-201 and Tc-99m) protocol performed with the Xpress3.Cardiac combines reduced doses with shorter scan times. Reduced-dose, shorter-scan-time rest Tl-201 imaging is followed by reduced-dose, shorter-scan-time Tc-99m stress imaging, rendering the procedure safer and more comfortable for the patient, while ensuring sustained/increased patient throughput for the practice: • Rest: Tl-201, 2 mCi (female) / 3 mCi (male); 20sec. per stop. • Stress: Tc-99m, 20 mCi (female) / 30 mCi (male); 10sec. per stop. UltraSPECT’s Xpress.Cardiac, Xpress3.Cardiac, and Xpress/Xact.BoneTM products are distributed in the USA exclusively by Cardinal Health. UltraSPECT products are distributed in the USA by Cardinal Health (www.cardinalhealth.com). For more information: www.ultraspect.com

 

Related Content

Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...